Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2022 | Story André Damons | Photo Jack once productions
The three directors of Epicutis Skincare
All smiles. The three directors of Epicutis Skincare; Dr Maanda Tshikororo, Chief Marketing Officer; Dr Lehlohonolo Makhakhe, Chief Executive officer and primary formulation scientist; and Mrs Mantwa Makhakhe, Chief Operating Officer, showing of some of their new skincare products

A senior lecturer and specialist in the Department of Dermatology at the University of the Free State (UFS) and his two associates, who are also postgraduate students at the university, have realised their dream when they launch their skincare company next month.
 

Dr Lehlohonolo Makhakhe, a full-time medical specialist (dermatologist), Dr Maanda Tshikororo, a medical doctor and a postgraduate student in the Department of Psychiatry, and Mrs Mantwa Makhakhe, who holds a BCom Economics degree and is currently completing her postgraduate diploma in financial planning, are the directors of Epicutis Skincare. Dr Makhakhe, who is also a PhD candidate registered with UFS, is the Chief Executive Officer and primary formulation scientist for the company, while Dr Tshikororo is the Chief Marketing Officer and Mrs Makhakhe the Chief Operating Officer.

The company is launching on 22 October 2022.

Narrowing the gap between treating skin ailments and manufacturing skincare products

According to Dr Makhakhe, who published the very first comprehensive African atlas on skin diseases commonly seen in the African setting,The African Atlas, synopsis and practical guide to clinical dermatology, says Epicutis is a company which will produce a range of personal skincare products. The range will comprise of products such as body lotions, body creams, petroleum jelly and a night cream. Since becoming a dermatologist, he has always wished to narrow the gap between being a clinician treating skin ailments and being involved in manufacturing skincare products.

“Creating products as a dermatologist has great benefits, because the products are created from a clinician’s perspective, with more intentional results. All ingredients used were carefully selected for their specific and scientifically proven benefits, they were then tested for stability in terms of viscosity, pH, microbiology in association with the South African Institute of Dermatology and other third parties,” says Dr Makhakhe. 

Ecstatic about the upcoming launch

Dr Tshikororo says this has been an adventure they have always thought of undertaking. “We finally reached a point of shifting from the comfort of dreaming about it, to taking action.” 

“We hope our company will play a notable role in creating permanent employment for the youth, and also have an impact on the growth of the economy of the Free State province and that of the country as well,” says Mrs Makhakhe. 
The three directors are ecstatic about the upcoming launch of their products, and optimistic that there is enough room for new, affordable, locally manufactured skincare products that are suitable for all family members.  

All products will be available at major retailers soon after the launch. Further information is available at the official website

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept